helicobacter pylori. Other specified bacterial agents as the cause of diseases classified to other chapters
Conditions
Interventions
Intervention 1: Omeprazol 20 mg, Amoxycilin 500 mg, and Clarithromycin 500mg twice a day, for 14 days. Intervention 2: Omeprazol 20mg, Amoxicillin 500mg, and Azithromycin 250mg twice a day, for 14 day
Treatment - Drugs
Omeprazol 20 mg, Amoxycilin 500 mg, and Clarithromycin 500mg twice a day, for 14 days
Omeprazol 20mg, Amoxicillin 500mg, and Azithromycin 250mg twice a day, for 14 days
Sponsors
Zanjan Univercity Of Medical Science
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: Presence of dyspepsia, positive results of H. pylori infection in two out of three diagnostic tests: anti H. pylori serology, H.pylori stool antigen (HpSAg) and Urease Breath Test (UBT) Exclusion criteria: history of previous treatment for H. Pylori, use of any of the investigated antibiotics in the previous six months, allergy to study medications, inability to perform UBT
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse evente and compliance. Timepoint: one visit a week. Method of measurement: Questionnarie. | — |
Secondary
| Measure | Time frame |
|---|---|
| H pylori eradication. Timepoint: Eight weeks after therepeutic regimen. Method of measurement: UBT. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactJamshid Vafaee Manesh
Qom Univrecity of Medical Sciences
Outcome results
None listed